Beam Therapeutics (BEAM) Other Non-Current Liabilities (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Other Non-Current Liabilities data on file, last reported at $5.4 million in Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 14.11% year-over-year to $5.4 million in Q1 2026; TTM through Mar 2026 was $5.4 million, a 14.11% decrease from a year earlier, with the FY2025 full-year figure at $173000.0, down 84.7% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $5.4 million, up from $173000.0 in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for BEAM reached as high as $12.8 million in Q1 2023 and fell as low as $173000.0 in Q4 2025.
• Historically, Other Non-Current Liabilities has averaged $4.0 million across 5 years, with a median of $2.7 million in 2023.
• Across the five-year window, Other Non-Current Liabilities slumped 99.19% in 2022 and soared 3371.48% in 2023, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $1.4 million in 2022, then soared by 97.61% to $2.7 million in 2023, then slumped by 58.46% to $1.1 million in 2024, then sank by 84.7% to $173000.0 in 2025, then surged by 3049.71% to $5.4 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $5.4 million in Q1 2026, $173000.0 in Q4 2025, and $266000.0 in Q3 2025.